| dc.contributor.author | Son, Mai Hong | en_US |
| dc.contributor.author | Bieu, Bui Quang | en_US |
| dc.contributor.author | Ha, Le Ngoc | en_US |
| dc.date.accessioned | 1399-07-09T12:22:48Z | fa_IR |
| dc.date.accessioned | 2020-09-30T12:22:48Z | |
| dc.date.available | 1399-07-09T12:22:48Z | fa_IR |
| dc.date.available | 2020-09-30T12:22:48Z | |
| dc.date.issued | 2016-01-01 | en_US |
| dc.date.issued | 1394-10-11 | fa_IR |
| dc.date.submitted | 2015-07-30 | en_US |
| dc.date.submitted | 1394-05-08 | fa_IR |
| dc.identifier.citation | Son, Mai Hong, Bieu, Bui Quang, Ha, Le Ngoc. (2016). Value of Dedicated Head and Neck 18F-FDG PET/CT Protocol in Detecting Recurrent and Metastatic Lesions in Post-surgical Differentiated Thyroid Carcinoma Patients with High Serum Thyroglobulin Level and Negative 131I Whole-body Scan. Asia Oceania Journal of Nuclear Medicine and Biology, 4(1), 12-18. doi: 10.7508/aojnmb.2016.04.003 | en_US |
| dc.identifier.issn | 2322-5718 | |
| dc.identifier.issn | 2322-5726 | |
| dc.identifier.uri | https://dx.doi.org/10.7508/aojnmb.2016.04.003 | |
| dc.identifier.uri | http://aojnmb.mums.ac.ir/article_5670.html | |
| dc.identifier.uri | https://iranjournals.nlai.ir/handle/123456789/420876 | |
| dc.description.abstract | Objective(s): In clinical practice, approximately 10-25% of post-surgical differentiated thyroid carcinoma (DTC) patients with high serum thyroglobulin (Tg) and negative <sup>131</sup>I whole-body scan (WBS) have poor prognosis due to recurrent or metastatic lesions after radioactive iodine treatment. The purpose of this study was to evaluate the value of <sup>18</sup>F-FDG PET/CT scan in DTC patients with high serum Tg level and negative 131I WBS.<br/>Methods: 69 post-surgical DTC patients with high serum Tg level and negative post ablation <sup>131</sup>I WBS were enrolled in this study. All DTC patients underwent head and neck ultrasound, CT scan and whole-body <sup>18</sup>F-FDG PET/CT, based on the dedicated head and neck protocol.<br/>Results: Overall, 92 lesions were detected in 43 (62.3%) out of 69 patients with positive <sup>18</sup>F-FDG PET/CT scan, compared to only 39 lesions detected on CT scan in 26 (37.7%) out of 69 patients. The sensitivity, accuracy and negative predictive value of <sup>18</sup>F-FDG PET/CT were 88%,87% and 76%, respectively, which were significantly higher than those of CT scan (67.2%, 54.3% and 48.8%, respectively) (P<0.01). Specificity and positive predictive value of <sup>18</sup>F-FDG PET/CT (90.5% and 95.2%, respectively) were similar to those of CT scan (95.2 % and 96.2 %, respectively) (P>0.05). The maximum standardized uptake value (SUV<sub>max</sub>) threshold was 4.5 with a good diagnostic value (sensitivity of 92.3 % and specificity of 100 %). The dedicated head and neck <sup>18</sup>F-FDG PET/CT protocol altered the treatment plan in 33 (47.8%) out of 69 DTC patients with high serum Tg level and negative 131I WBS.<br/>Conclusion: Dedicated head and neck <sup>18</sup>F-FDG PET/CT protocol showed a higher diagnostic value, compared to CT scan and played an important role in detecting recurrent or metastatic lesions in post-surgical DTC patients with high serum Tg level and negative <sup>131</sup>I WBS. | en_US |
| dc.format.extent | 857 | |
| dc.format.mimetype | application/pdf | |
| dc.language | English | |
| dc.language.iso | en_US | |
| dc.publisher | Asia Oceania Federation of Nuclear Medicine & Biology | en_US |
| dc.relation.ispartof | Asia Oceania Journal of Nuclear Medicine and Biology | en_US |
| dc.relation.isversionof | https://dx.doi.org/10.7508/aojnmb.2016.04.003 | |
| dc.subject | 18F-FDG PET/CT | en_US |
| dc.subject | Differentiated Thyroid Carcinoma | en_US |
| dc.subject | Head and neck | en_US |
| dc.subject | Thyroglobulin | en_US |
| dc.subject | Thyroid | en_US |
| dc.title | Value of Dedicated Head and Neck 18F-FDG PET/CT Protocol in Detecting Recurrent and Metastatic Lesions in Post-surgical Differentiated Thyroid Carcinoma Patients with High Serum Thyroglobulin Level and Negative 131I Whole-body Scan | en_US |
| dc.type | Text | en_US |
| dc.type | Original Article | en_US |
| dc.contributor.department | Department of Nuclear Medicine, Tran Hung Dao Hospital, Hanoi, Vietnam | en_US |
| dc.contributor.department | Department of Nuclear Medicine, Tran Hung Dao Hospital, Hanoi, Vietnam | en_US |
| dc.contributor.department | Department of Nuclear Medicine, Tran Hung Dao Hospital, Hanoi, Vietnam | en_US |
| dc.citation.volume | 4 | |
| dc.citation.issue | 1 | |
| dc.citation.spage | 12 | |
| dc.citation.epage | 18 | |
| nlai.contributor.orcid | 0000-0002-0554-0407 | |